GlucoTab

DEVICE5 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, Medical University of Graz, Steno Diabetes Center Copenhagen

Conditions

CGMDiabetes Mellitus Type 2InfectionType 2 DiabetesType 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)Type 2 Diabetes, Insulin Requiring

Phase 2

Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2

CompletedNCT03387787

Insel Gruppe AG, University Hospital BernType 2 Diabetes Mellitus

Start: 2018-01-30End: 2020-01-30Updated: 2023-03-16

Unknown Phase

DigiDiab Pilot: Impact Study Hospital

RecruitingNCT06605872

Medical University of GrazType 2 Diabetes

Start: 2025-04-01End: 2025-10-31Target: 500Updated: 2025-08-01

DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care

RecruitingNCT06605859

Medical University of GrazType 2 Diabetes

Start: 2025-04-08End: 2025-09-15Target: 40Updated: 2025-08-03

DigiDiab Evaluation Domiciliary Nursing Care

CompletedNCT06616779

Medical University of GrazType 2 Diabetes, Type 2 Diabetes, Insulin Requiring, Type 2 Diabetes Mellitus (T2DM)

Start: 2024-11-30End: 2025-04-15Updated: 2025-08-01

Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care

Not yet recruitingNCT07645079

Steno Diabetes Center CopenhagenCGM, Diabetes Mellitus Type 2, Infection

Start: 2026-07-01End: 2027-07-30Target: 92Updated: 2026-06-12